PEN

#768
Penumbra, Inc.
332.0550 USD
+0.19%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
331.8800
332.2400
Intervallo Annuale
221.2600
362.4100
Variazione giornaliera
+0.19%
Variazione Mensile
-1.35%
Variazione di 6 mesi
+27.71%
Variazione Annuale
+27.71%
Chiusura Precedente
331.4200
Apertura
331.9850
Bid
Ask
Minimo
331.8800
High
332.2400
Volume
208
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 13.0309 B
  • Employee 4 700
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
68.79
Rapporto prezzo/fatturato
8.7

Penumbra Inc

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

Notizie